The competitive NMDA antagonist CPP blocks MK-801-elicited popping behavior in mice

Neuropsychopharmacology. 1996 Oct;15(4):329-31. doi: 10.1016/0893-133X(95)00236-7.

Abstract

In the current investigation, the ability of CPP (3-(2-carboxypiperazine-4-yl) propyl-1-phosphate) to elicit mouse popping behavior in a manner similar to that of MK-801 was studied. Unlike MK-801, CPP (3.2-32 mg/kg) did not elicit any popping. The data show that a reduction in NMDA-mediated neural transmission alone is not sufficient to elicit popping behavior in mice. Moreover, pretreatment of mice with CPP attenuated MK-801's ability to elicit popping. These results suggest that popping requires the channel to be in the "active", or open, configuration and that it depends on MK-801's access and binding to its unique site in the hydrophobic channel domain.

Publication types

  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Animals
  • Behavior, Animal / drug effects*
  • Dizocilpine Maleate / pharmacology*
  • Dose-Response Relationship, Drug
  • Male
  • Mice
  • Mice, Inbred Strains
  • Piperazines / pharmacology*
  • Receptors, N-Methyl-D-Aspartate / antagonists & inhibitors*

Substances

  • Piperazines
  • Receptors, N-Methyl-D-Aspartate
  • 3-(2-carboxypiperazine-4-yl)propyl-1-phosphate
  • Dizocilpine Maleate